左子分支加速心力衰竭和左子分支阻塞患者的左心室喷射小部分轻微减少和保存
Yang Ye1, Xueying Chen2, Lang He3
1Department of Cardiology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China; Key Laboratory of Cardiovascular Intervention and Regenerative Medicine of Zhejiang Province, Hangzhou, Zhejiang, China.
The Canadian journal of cardiology
|September 15, 2023
概括
左束枝节奏 (LBBP) 在心力衰竭 (HF) 和左束枝节阻塞 (LBBB) 患者中显著改善了心脏功能并逆转了重塑. 在轻微减少喷射分数 (HFmrEF) 的HF和保持喷射分数 (HFpEF) 的HF组中都观察到改善.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
- 心脏衰竭研究研究
背景情况:
- 左捆支部阻塞 (LBBB) 可以使心力衰竭 (HF) 恶化.
- 有限的数据存在于LBBB患者的HF和轻微减少的喷射分数 (HFmrEF) 或保存的喷射分数 (HFpEF).
- 左捆枝节奏 (LBBP) 是这些患者的潜在治疗方法.
研究的目的:
- 评估LBBP对心脏功能和心脏重塑的长期影响.
- 为了评估症状性HF患者LBBB,HFmrEF和HFpEF的结局.
主要方法:
- 对50名患有LBBB,HFmrEF/HFpEF且接受LBBP的非缺血性心肌病患者进行前性研究.
- 在基线和1年随访时记录了心声和参数.
- 患者被跟踪了12个月.
主要成果:
- 一年后,左心室喷射分数 (LVEF) 从46.5%显著改善到60.0% (P < 0.001).
- 与HFpEF组相比,HFmrEF组的LVEF改善率和超级响应率更高.
- 所有患者都完成了1年的随访.
结论:
- 在LBBB患者中,LBBP改善症状并逆转心脏重塑,患者有症状的HF.
- 甚至在HFpEF患者中也观察到LBBP的积极影响.
- 在HFmrEF组中,LBBP的重同步效应更加明显.
相关概念视频
Heart Failure Drugs: β-Blockers
363
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
363
Heart Failure IV: Classification and Diagnostic Evaluation
19
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
19
Cardiomyopathy III: Hypertrophic Cardiomyopathy
16
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Mitral Stenosis I: Introduction
15
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
15
Heart Failure II: Pathophysiology
15
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
15
Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11


